ArticleMolecular therapy. Oncology2026

Targeted attack: Harnessing myelin-specific plasmolipin for suppression of neuroblastoma and glioblastoma.

Pavel Spirin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.